What's Happening?
The global genomics market is expected to grow significantly, from $47.07 billion in 2025 to $85.09 billion by 2030, at a compound annual growth rate (CAGR) of 12.6%. This growth is driven by advancements in next-generation sequencing (NGS) platforms
and the expanding role of genomics in drug discovery, diagnostics, and agriculture. The products segment, which includes reagents, kits, and instruments, is projected to dominate the market due to continuous innovations in genomics technologies. The Asia Pacific region is anticipated to experience the fastest growth, supported by government funding, expanding healthcare infrastructure, and the rising adoption of precision medicine.
Why It's Important?
The projected growth of the genomics market underscores the increasing importance of genomics in various sectors, including healthcare and agriculture. The advancements in genomics technologies are enabling more precise and effective treatments, particularly in the field of precision medicine. This growth is likely to drive further investments in genomics research and development, leading to new innovations and applications. The expansion in the Asia Pacific region highlights the global nature of this growth, with significant implications for healthcare systems and industries worldwide.
